Enterprise AI Analysis
Pre-training Genomic Language Models with Variants for Enhanced Functional Genomics
This research introduces UKBioBERT, a genomic language model (gLM) pre-trained with genetic variants from UK BioBank, and UKBioFormer/UKBioZoi, models that fuse UKBioBERT with state-of-the-art sequence-to-function architectures. We demonstrate that UKBioBERT generates highly informative DNA sequence embeddings, significantly improving gene expression prediction in cell lines and enabling more accurate individualized gene expression predictions across cohorts. This work highlights the critical value of integrating genomic language models with sequence-to-function approaches to advance functional genomics.
Executive Impact at a Glance
Our innovative approach transforms complex genomic data into actionable insights, driving predictability and uncovering critical genetic mechanisms.
0
Gene Representation Quality (Avg Score)
0
Cell-Type Exp. Prediction (PCC)
0
Genes with Improved Indiv. Prediction
0
eQTL Direction Prediction Accuracy
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
UKBioBERT: Learning Superior Gene Representations from Variants
Our novel UKBioBERT model, pre-trained with over 13 million genetic variants from UK BioBank, significantly outperforms existing genomic language models like DNABERT2 and HyenaDNA in capturing gene functional context. By focusing on variant-rich data, UKBioBERT generates more informative DNA sequence embeddings, enabling clearer clustering of genes by function. This capability is crucial for identifying functionally distinct DNA sequences and provides a robust foundation for downstream applications.
0.423
Highest Average Gene Clustering Score (vs. DNABERT2 0.319)
Improving Cell-Type Specific Gene Expression with UKBioBERT Embeddings
Integrating UKBioBERT embeddings with advanced sequence-to-function architectures like EPInformer dramatically enhances cell-type-specific gene expression prediction. Our approach, UKBioFormer, leverages the rich genomic context encoded by UKBioBERT to achieve superior accuracy and stability across various cell lines (e.g., K562, GM12878) and experimental techniques (CAGE-seq, RNA-seq). This demonstrates the power of variant-aware genomic language models in refining predictions at a granular biological level.
0.902
Average PCC for GM12878 CAGE-seq (UKBioFormer vs. EPInformer default 0.884)
Recovering Predictability: Individualized Gene Expression Across Cohorts
UKBioBERT-derived embeddings prove instrumental in improving individualized gene expression prediction, even across diverse populations and confounding factors like age, gender, and ancestry. When combined with Enformer for fine-tuning (UKBioFormer), our models achieve robust performance, often surpassing baselines like ElasticNet and Performer, especially for highly predictable genes. This generalizability is critical for applying insights from population-level genomics to personalized medicine.
63.3%
UKBioFormer outperforms Performer in highly predictable genes for individual expression.
Decoding Variant Effects: eQTL Identification and In-Silico Mutagenesis
Our UKBioFormer model provides a powerful framework for identifying expression quantitative trait loci (eQTLs) and interpreting genetic variant effects. By utilizing neural network explainability tools like In Silico Mutagenesis (ISM), UKBioFormer can predict the correct direction of eQTL effects with high accuracy (>70%) and precisely match observed effect sizes for critical genes. This capability allows for deep mechanistic insights into how specific genetic variants influence gene expression, accelerating discovery of regulatory elements and potential therapeutic targets.
71%
UKBioFormer predicts correct eQTL signs, outperforming Enformer (53%) and Performer (68%).
Enterprise Process Flow: From Variants to Functional Insights
Pre-train UKBioBERT with UK BioBank variants (Masked Language Modeling)
→
Generate informative DNA sequence embeddings from UKBioBERT
→
Fuse UKBioBERT embeddings with state-of-the-art sequence-to-function models (Enformer/Borzoi)
→
Fine-tune fused models (UKBioFormer/UKBioZoi) for gene expression prediction
→
Perform in-silico mutation analysis and eQTL identification
→
Advance functional genomics and variant effect understanding
| Feature/Model | DNABERT2 | Enformer | Performer | UKBioBERT | UKBioFormer | UKBioZoi |
|---|---|---|---|---|---|---|
| Pre-training Data | Reference | Population | Population | Variants + Ref | Variants + Ref | Variants + Ref |
| Learning Strategy | MLM | Supervised | Supervised | MLM (Variant-aware) | MLM + Fine-tuning (PEFT) | MLM + Fine-tuning (PEFT) |
| Gene Rep. Quality | Good | N/A | N/A | Excellent (Avg Score 0.423) | N/A | N/A |
| Cell-type Exp. Pred. (PCC) | Good | Good | Good | Good (with EPInformer) | Excellent (> 0.9) | Good |
| Indiv. Exp. Pred. (Improvement) | Good (with ElasticNet) | Limited (Zero-shot) | Good (Fine-tuned) | Good (with ElasticNet) | Excellent (Improved in 63.3% genes) | Good |
| eQTL Direction Predict. | N/A | 53% | 68% | N/A | 71% | N/A |
| Computational Cost | Moderate | High | High | Moderate | Moderate (PEFT) | Low (PEFT) |
| Main Benefit | General NLP | Tissue-spec. | Personalization | Contextual Variants | High Accuracy & Interpretability | Efficiency |
Case Study: Unveiling Regulatory Mechanisms of the JUP Gene
We applied UKBioFormer to the JUP gene, known for its roles in cell adhesion and signaling, demonstrating its ability to uncover specific variant effects. For eQTL rs9910080 within a JUP enhancer, UKBioFormer accurately predicted that an alternative allele (C instead of T) leads to a decrease in gene expression. Our analysis, including integrated gradients and In Silico Mutagenesis (ISM), highlighted significant motifs like JUN-class (TGAGTCAC), indicating their regulatory importance. This precision allows for deep mechanistic understanding of genetic contributions to phenotypes.
Calculate Your Potential ROI
See how integrating advanced genomic AI can translate into significant operational efficiencies and research breakthroughs for your organization.
Estimated Annual Savings
$0
Research Hours Reclaimed Annually
0
Your Path to Advanced Functional Genomics
Our phased implementation roadmap ensures a seamless integration of UKBioFormer into your existing research pipelines.
Phase 01: Initial Data Integration & UKBioBERT Pre-training
We begin by integrating your specific genomic datasets with UK BioBank data to re-train or fine-tune UKBioBERT, ensuring it captures the nuances of your research focus and populations.
Phase 02: Model Fusion & UKBioFormer Development
The UKBioBERT embeddings are then fused with advanced sequence-to-function architectures (Enformer/Borzoi), creating bespoke UKBioFormer or UKBioZoi models optimized for your prediction tasks.
Phase 03: Performance Benchmarking & Validation
Rigorous testing and validation against your ground truth data ensure the models achieve superior accuracy in gene expression prediction across cell types and individuals.
Phase 04: Interpretability Analysis & eQTL Discovery
We implement neural network explainability tools to dissect variant effects, identify eQTLs, and uncover novel regulatory motifs, providing deep biological insights.
Phase 05: Deployment & Ongoing Monitoring
The validated models are deployed into your research environment, with continuous monitoring and iterative refinement to adapt to evolving data and research questions.
Ready to Transform Your Genomic Research?
Our team of experts is ready to discuss how UKBioFormer can accelerate your discoveries and provide deeper insights into functional genomics.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat